APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lyme Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026

Report ID 174009530426 December 2025197 pages

Choose your research edition.

Industry ResearchLyme Disease Vaccine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Lyme Disease Vaccine Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Lyme Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Lyme Disease Vaccine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Lyme Disease Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lyme Disease Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lyme Disease Vaccine market include Merck, Zoetis and Merial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lyme Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lyme Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lyme Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lyme Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Lyme Disease Vaccine Segment by Company

Merck

Zoetis

Merial

Lyme Disease Vaccine Segment by Type

Inactivated Vaccine

Attenuated Vaccine

Lyme Disease Vaccine Segment by Application

Hospital

Scientific Research

Others

Lyme Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lyme Disease Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lyme Disease Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lyme Disease Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Lyme Disease Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyme Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lyme Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyme Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lyme Disease Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lyme Disease Vaccine industry.

Chapter 3: Detailed analysis of Lyme Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lyme Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lyme Disease Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lyme Disease Vaccine Industry Trends Table 2. Lyme Disease Vaccine Industry Drivers Table 3. Lyme Disease Vaccine Industry Opportunities and Challenges Table 4. Lyme Disease Vaccine Industry Restraints Table 5. Global Lyme Disease Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lyme Disease Vaccine Revenue Share by Company (2021-2026) Table 7. Global Lyme Disease Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lyme Disease Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Lyme Disease Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lyme Disease Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lyme Disease Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Lyme Disease Vaccine Company, Product Type & Application Table 13. Global Lyme Disease Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lyme Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inactivated Vaccine Table 18. Significant Companies of Attenuated Vaccine Table 19. Global Lyme Disease Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lyme Disease Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lyme Disease Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lyme Disease Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Lyme Disease Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Lyme Disease Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lyme Disease Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lyme Disease Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lyme Disease Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Lyme Disease Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Scientific Research Table 31. Significant Companies of Others Table 32. Global Lyme Disease Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lyme Disease Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Lyme Disease Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Lyme Disease Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Lyme Disease Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Lyme Disease Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lyme Disease Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lyme Disease Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lyme Disease Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Lyme Disease Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lyme Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Lyme Disease Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Lyme Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Lyme Disease Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Lyme Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lyme Disease Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lyme Disease Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Lyme Disease Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lyme Disease Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Lyme Disease Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lyme Disease Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Lyme Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Lyme Disease Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Lyme Disease Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lyme Disease Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Lyme Disease Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lyme Disease Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck Lyme Disease Vaccine Product Portfolio Table 68. Merck Recent Development Table 69. Zoetis Company Information Table 70. Zoetis Business Overview Table 71. Zoetis Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Zoetis Lyme Disease Vaccine Product Portfolio Table 73. Zoetis Recent Development Table 74. Merial Company Information Table 75. Merial Business Overview Table 76. Merial Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merial Lyme Disease Vaccine Product Portfolio Table 78. Merial Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Lyme Disease Vaccine Distributors List Table 82. Lyme Disease Vaccine Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Lyme Disease Vaccine Product Image Figure 2. Global Lyme Disease Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lyme Disease Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Lyme Disease Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lyme Disease Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inactivated Vaccine Image Figure 10. Attenuated Vaccine Image Figure 11. Global Lyme Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lyme Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lyme Disease Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Lyme Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lyme Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lyme Disease Vaccine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Scientific Research Image Figure 19. Others Image Figure 20. Global Lyme Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lyme Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lyme Disease Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Lyme Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lyme Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lyme Disease Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Lyme Disease Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lyme Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lyme Disease Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lyme Disease Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lyme Disease Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Inactivated Vaccine
  • Attenuated Vaccine
Applications
  • Hospital
  • Scientific Research
  • Others
Companies covered
  • Merck
  • Zoetis
  • Merial

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lyme Disease Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Lyme Disease Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Lyme Disease Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lyme Disease Vaccine Market Dynamics
  1. 2.1 Lyme Disease Vaccine Industry Trends
  2. 2.2 Lyme Disease Vaccine Industry Drivers
  3. 2.3 Lyme Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Lyme Disease Vaccine Industry Restraints
3 Lyme Disease Vaccine Market by Company
  1. 3.1 Global Lyme Disease Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Lyme Disease Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Lyme Disease Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Lyme Disease Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Lyme Disease Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Lyme Disease Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Lyme Disease Vaccine Company Product Type and Application
  8. 3.8 Global Lyme Disease Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lyme Disease Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lyme Disease Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lyme Disease Vaccine Market by Type
  1. 4.1 Lyme Disease Vaccine Type Introduction
  2. 4.1.1 Inactivated Vaccine
  3. 4.1.2 Attenuated Vaccine
  4. 4.2 Global Lyme Disease Vaccine Sales Volume by Type
  5. 4.2.1 Global Lyme Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lyme Disease Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lyme Disease Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lyme Disease Vaccine Sales Value by Type
  9. 4.3.1 Global Lyme Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lyme Disease Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lyme Disease Vaccine Sales Value Share by Type (2021-2032)
5 Lyme Disease Vaccine Market by Application
  1. 5.1 Lyme Disease Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Scientific Research
  4. 5.1.3 Others
  5. 5.2 Global Lyme Disease Vaccine Sales Volume by Application
  6. 5.2.1 Global Lyme Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lyme Disease Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lyme Disease Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lyme Disease Vaccine Sales Value by Application
  10. 5.3.1 Global Lyme Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lyme Disease Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lyme Disease Vaccine Sales Value Share by Application (2021-2032)
6 Lyme Disease Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lyme Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Lyme Disease Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Lyme Disease Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Lyme Disease Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lyme Disease Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lyme Disease Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lyme Disease Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Lyme Disease Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lyme Disease Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lyme Disease Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lyme Disease Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lyme Disease Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lyme Disease Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
7 Lyme Disease Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lyme Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lyme Disease Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Lyme Disease Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Lyme Disease Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Lyme Disease Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lyme Disease Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lyme Disease Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Lyme Disease Vaccine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Lyme Disease Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Merial
  14. 8.3.1 Merial Company Information
  15. 8.3.2 Merial Business Overview
  16. 8.3.3 Merial Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merial Lyme Disease Vaccine Product Portfolio
  18. 8.3.5 Merial Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lyme Disease Vaccine Value Chain Analysis
  2. 9.1.1 Lyme Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lyme Disease Vaccine Sales Mode & Process
  6. 9.2 Lyme Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lyme Disease Vaccine Distributors
  9. 9.2.3 Lyme Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst